DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 0.00 0.00%
S&P 500 2,088.87 -0.27 -0.01%
market minute promo

Covidien (NYSE: COV)

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

COV $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $1.44 (1.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 0
Average Daily Volume 0
Current FY EPS $4.31




Healthcare IT

Covidien (COV) Description

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings. Website:

News & Commentary

3 Specialty-Drug Makers Trying to Spark Investor Interest -- Are They Buys?

Payer pushback has caused specialty-drug companies to crater, but these three companies' shares might be ready to head higher.

How 1 Specialty-Drug Maker Hopes to Win Back Investor Trust

An increase to its share buyback program and promises to reduce debt could help spark Mallinkcrodt Pharmaceutical's shares.

Synergy Rallies 18% Following News of Paulson & Co. Stake

John Paulson Continues To Bet On Health Care And TV

David Einhorn Still Focused On Tech While Escaping Health Care In Q1

The Latest Stock Picks From Cliff Asness, AQR Capital's 13F

Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2015 Update

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Why Medtronic-Covidien Deal Will Lead To Strong 2015 Performance

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

See More COV News...

COV's Top Competitors

COV $0.00 (0.00%)
Current stock: COV
$0.00 (0.00%)
Current stock:
MDT $76.56 (0.00%)
Current stock: MDT
SYK $97.22 (0.63%)
Current stock: SYK